• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项单中心 11 例重症 COVID-19 肺炎住院患者中 SARS-CoV-2 与肺炎链球菌合并感染的回顾性研究。

A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.

机构信息

Department of Internal Medicine, AMITA Health Saint Francis Hospital, Evanston, IL, USA.

Critical Care Units, AMITA Health Saint Francis Hospital, Evanston, IL, USA.

出版信息

Med Sci Monit. 2020 Nov 14;26:e928754. doi: 10.12659/MSM.928754.

DOI:10.12659/MSM.928754
PMID:33188161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7673066/
Abstract

BACKGROUND A lethal synergism between the influenza virus and Streptococcus pneumoniae has been identified. However, bacterial coinfection is considered relatively infrequent in hospitalized patients with COVID-19, and the co-prevalence of Streptococcus pneumoniae is low. MATERIAL AND METHODS We retrospectively analyzed the clinical characteristics and outcomes of patients subsequently admitted to AMITA Health Saint Francis Hospital between March 1 and June 30, 2020, with documented SARS-CoV-2 and S. pneumoniae coinfection. RESULTS We identified 11 patients with S. pneumoniae coinfection. The median age was 77 years (interquartile range [IQR], 74-82 years), 45.5% (5/11) were males, 54.5% (6/11) were white, and 90.9% (10/11) were long-term care facility (LTCF) residents. The median length of stay was 7 days (IQR, 6-8 days). Among 11 patients, 4 were discharged in stable condition and 7 had died, resulting in an inpatient mortality rate of 64%. CONCLUSIONS At our center, 11 patients with COVID-19 pneumonia who had confirmed infection with SARS-CoV-2 were diagnosed with Streptococcus pneumoniae infection while in hospital. All patients had pneumonia confirmed on imaging and a nonspecific increase in markers of inflammation. The in-hospital mortality rate of 64% (7 patients) was higher in this group than in previous reports. This study highlights the importance of monitoring bacterial coinfection in patients with viral lung infection due to SARS-CoV-2.

摘要

背景

已确定流感病毒和肺炎链球菌之间存在致命协同作用。然而,在 COVID-19 住院患者中,细菌合并感染被认为相对较少,肺炎链球菌的合并感染率较低。

材料和方法

我们回顾性分析了 2020 年 3 月 1 日至 6 月 30 日期间因 COVID-19 入住 AMITA 健康圣弗朗西斯医院并确诊同时感染 SARS-CoV-2 和肺炎链球菌的患者的临床特征和结局。

结果

我们共发现 11 例肺炎链球菌合并感染患者。中位年龄为 77 岁(四分位距[IQR],74-82 岁),45.5%(5/11)为男性,54.5%(6/11)为白人,90.9%(10/11)为长期护理机构(LTCF)居民。中位住院时间为 7 天(IQR,6-8 天)。11 例患者中,4 例出院时病情稳定,7 例死亡,住院病死率为 64%。

结论

在我们中心,11 例确诊感染 SARS-CoV-2 的 COVID-19 肺炎患者在住院期间被诊断为肺炎链球菌感染。所有患者的影像学均证实有肺炎,炎症标志物均有非特异性升高。该组住院病死率(7 例患者)为 64%,高于以往报告。本研究强调了由于 SARS-CoV-2 引起的病毒性肺部感染患者中监测细菌合并感染的重要性。

相似文献

1
A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.一项单中心 11 例重症 COVID-19 肺炎住院患者中 SARS-CoV-2 与肺炎链球菌合并感染的回顾性研究。
Med Sci Monit. 2020 Nov 14;26:e928754. doi: 10.12659/MSM.928754.
2
Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.肺炎链球菌尿抗原检测对降低 COVID-19 合并感染患者死亡率的有效性:一项临床研究。
Medicina (Kaunas). 2020 Oct 29;56(11):572. doi: 10.3390/medicina56110572.
3
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.新型冠状病毒病(COVID-19)大流行对侵袭性肺炎球菌病的影响以及与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)发生肺炎球菌合并感染的风险:英格兰全国前瞻性队列研究。
Clin Infect Dis. 2021 Mar 1;72(5):e65-e75. doi: 10.1093/cid/ciaa1728.
4
Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV.肺炎球菌结合疫苗对有和无 HIV 的儿童因冠状病毒相关肺炎住院的保护作用。
mBio. 2021 Jan 8;12(1):e02347-20. doi: 10.1128/mBio.02347-20.
5
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.在中东呼吸综合征冠状病毒流行地区住院的 COVID-19 患者的临床特征和转归。
J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi: 10.2991/jegh.k.200806.002.
6
COVID-19 and Mycoplasma pneumoniae: SARS-CoV-2 false positive or coinfection?新型冠状病毒肺炎与肺炎支原体:严重急性呼吸综合征冠状病毒2假阳性还是合并感染?
Int J Dermatol. 2020 Oct;59(10):1282-1283. doi: 10.1111/ijd.15090. Epub 2020 Aug 7.
7
Bacterial Co-infection in Hospitalized Children with Mycoplasma pneumoniae Pneumonia.住院支原体肺炎患儿的细菌合并感染
Indian Pediatr. 2016 Oct 8;53(10):879-882. doi: 10.1007/s13312-016-0951-8.
8
Atypical bacterial co-infections among patients with COVID-19: A study from India.COVID-19 患者中的非典型细菌合并感染:来自印度的研究。
J Med Virol. 2022 Jan;94(1):303-309. doi: 10.1002/jmv.27324. Epub 2021 Sep 15.
9
Coinfection in SARS-CoV-2 Infected Children Patients.新冠病毒感染患儿的合并感染。
J Infect Dev Ctries. 2021 Jun 30;15(6):761-765. doi: 10.3855/jidc.14314.
10
SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.SARS-CoV-2 诱导的免疫失调以及 COVID-19 患者需要更高的临床警惕以识别合并感染和继发感染。
J Microbiol Immunol Infect. 2021 Feb;54(1):105-108. doi: 10.1016/j.jmii.2020.08.016. Epub 2020 Sep 8.

引用本文的文献

1
NEDD4 Regulated Pyroptosis Occurred from Co-infection between Influenza A Virus and Streptococcus pneumoniae.NEDD4 调控的细胞焦亡发生于甲型流感病毒与肺炎链球菌的合并感染。
J Microbiol. 2023 Aug;61(8):777-789. doi: 10.1007/s12275-023-00076-y. Epub 2023 Oct 4.
2
Changes in the Incidence of Invasive Pneumococcal Disease in Calgary, Canada, during the SARS-CoV-2 Pandemic 2020-2022.2020 - 2022年新冠疫情期间加拿大卡尔加里侵袭性肺炎球菌病发病率的变化
Microorganisms. 2023 May 18;11(5):1333. doi: 10.3390/microorganisms11051333.
3
Interpretation of chest radiography in patients with known or suspected SARS-CoV-2 infection: what we learnt from comparison with computed tomography.疑似或已知 SARS-CoV-2 感染患者的胸部 X 线摄影解读:与计算机断层扫描比较得出的经验
Emerg Radiol. 2023 Jun;30(3):363-376. doi: 10.1007/s10140-022-02105-6. Epub 2022 Nov 26.
4
Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.新冠病毒感染期间,继发性细菌性感染的易感性和严重程度呈时间依赖性增加。
Front Immunol. 2022 May 12;13:894534. doi: 10.3389/fimmu.2022.894534. eCollection 2022.
5
Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infection during SARS-CoV-2 Infection.新型冠状病毒感染期间继发性细菌感染易感性和严重程度的时间依赖性增加
bioRxiv. 2022 Mar 1:2022.02.28.482305. doi: 10.1101/2022.02.28.482305.
6
Promising Expectations for Pneumococcal Vaccination during COVID-19.新冠疫情期间肺炎球菌疫苗接种的前景展望
Vaccines (Basel). 2021 Dec 20;9(12):1507. doi: 10.3390/vaccines9121507.
7
Mechanisms Underlying Pneumococcal Transmission and Factors Influencing Host-Pneumococcus Interaction: A Review.肺炎球菌传播的潜在机制及影响宿主-肺炎球菌相互作用的因素:综述
Front Cell Infect Microbiol. 2021 Apr 28;11:639450. doi: 10.3389/fcimb.2021.639450. eCollection 2021.
8
Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.新型冠状病毒肺炎中的微生物共感染:相关共生菌群及发病机制的潜在机制。
Microb Pathog. 2021 Jul;156:104941. doi: 10.1016/j.micpath.2021.104941. Epub 2021 May 4.
9
A Double Whammy: A Case Report and Review of the Literature on Pneumococcal Coinfection in COVID-19 Patients.双重打击:1例COVID-19患者肺炎球菌合并感染的病例报告及文献综述
Cureus. 2021 Feb 13;13(2):e13322. doi: 10.7759/cureus.13322.

本文引用的文献

1
Low rate of bacterial co-infection in patients with COVID-19.新冠病毒病患者细菌合并感染率低。
Lancet Microbe. 2020 Jun;1(2):e62. doi: 10.1016/S2666-5247(20)30036-7. Epub 2020 Jun 8.
2
Co-infections: potentially lethal and unexplored in COVID-19.合并感染:在新冠病毒病中可能致命且未被探索。
Lancet Microbe. 2020 May;1(1):e11. doi: 10.1016/S2666-5247(20)30009-4. Epub 2020 Apr 24.
3
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.COVID-19 住院患者合并感染和再感染的发生率:一项回顾性队列研究。
Clin Microbiol Infect. 2021 Jan;27(1):83-88. doi: 10.1016/j.cmi.2020.07.041. Epub 2020 Jul 31.
4
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染:英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
5
Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia.新型冠状病毒肺炎患者中的细菌和真菌感染。
Infez Med. 2020 Jun 1;28(suppl 1):29-36.
6
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染:系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
7
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体:一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
8
Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients.感染患者中SARS-CoV-2与多种常见呼吸道病原体的合并感染。
Sci China Life Sci. 2020 Apr;63(4):606-609. doi: 10.1007/s11427-020-1668-5. Epub 2020 Mar 5.
9
Lethal Synergism between Influenza and .流感与……之间的致命协同作用
J Infect Pulm Dis. 2016 Oct;2(2). doi: 10.16966/2470-3176.114. Epub 2016 Apr 30.
10
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.细菌性肺炎在大流行性流感致死原因中占主要作用:对大流行性流感防范的启示
J Infect Dis. 2008 Oct 1;198(7):962-70. doi: 10.1086/591708.